Acute treatment of migraine in patients with cardiovascular disease or risk factors

被引：0
|
作者：
Golden, W. M. [1 ]
Bigal, M. E. [1 ]
Yu, J. [2 ]
Hu, X. H. [1 ]
Brixner, D., I [2 ]
Lipton, R. B. [3 ]
LaFleur, J. [2 ]
机构：
[1] Merck & Co Inc, Global Outcomes Res & Reimbursement, Whitehouse Stn, NJ USA
[2] Univ Utah, Pharmacotherapy Outcomes Res Ctr, Salt Lake City, UT USA
[3] Albert Einstein Coll Med, Dept Neurol, Bronx, NY 10467 USA
来源：
CEPHALALGIA | 2009年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：15 / 15
页数：1
相关论文
共 50 条
  • [1] Acute Treatment of Migraine in Patients with Cardiovascular Disease or Risk Factors
    Golden, Wendy M.
    Bigal, Marcelo E.
    Yu, Junhua
    Hu, Henry
    Brixner, Diana I.
    Lipton, Richard B.
    LaFleur, Joanne
    [J]. NEUROLOGY, 2010, 74 (09) : A581 - A581
  • [2] Patterns of acute migraine medication use in individuals with cardiovascular disease or risk factors
    Golden, W. M.
    Bigal, M. E.
    Yu, J.
    Hu, X. H.
    Brixner, D., I
    Lipton, R. B.
    LaFleur, J.
    [J]. CEPHALALGIA, 2009, 29 : 15 - 16
  • [3] Migraine patients should be cautiously followed for risk factors leading to cardiovascular disease
    Ferreira da Silva, Ivan Rocha
    de Freitas, Gabriel R.
    [J]. ARQUIVOS DE NEURO-PSIQUIATRIA, 2013, 71 (02) : 119 - 124
  • [4] Preventive Treatment for Patients With Migraine and Cardiovascular Disease
    Panesar, Kiran
    [J]. US PHARMACIST, 2018, 43 (12) : 38 - 44
  • [5] Inadequate treatment of cardiovascular disease and cardiovascular disease risk factors in dialysis patients: A commentary
    Culleton, BF
    Hemmelgarn, B
    [J]. SEMINARS IN DIALYSIS, 2004, 17 (05) : 342 - 345
  • [6] Migraine and cardiovascular risk factors
    Konstantinos Karakousis
    Konstantinos Karamitsos
    Argiroula-Vasiliki Karadonta
    Ioanna Karadonta
    [J]. Annals of General Psychiatry, 7 (Suppl 1)
  • [7] Pooled Analysis of Cardiovascular Safety With Fremanezumab Treatment in Patients With Migraine by Number of Cardiovascular or Cerebrovascular Risk Factors
    Juergens, T.
    Kessler, Y.
    Cohen, J. M.
    Ning, X.
    Yang, R.
    Diener, H. -C.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2020, 27 : 164 - 164
  • [8] Pooled Analysis of Cardiovascular Safety With Fremanezumab Treatment in Patients With Migraine by Number of Cardiovascular or Cerebrovascular Risk Factors
    Juergens, T. P.
    Ning, X.
    Kessler, Y.
    Cohen, J. M.
    Yang, R.
    Diener, H.
    [J]. HEADACHE, 2020, 60 : 3 - 4
  • [9] Migraine and risk of cardiovascular disease
    Adelborg K
    Szépligeti SK
    Holland-Bill L
    [J]. 中华物理医学与康复杂志, 2018, 40 (05) : 392 - 392
  • [10] Pooled Analysis of Cardiovascular Safety with Fremanezumab Treatment in Patients with Migraine by Cardiovascular History and Number of Cardiovascular or Cerebrovascular Risk Factors
    Nahas, Stephanie J.
    Juergens, Tim P.
    Kessler, Yoel
    Ning, Xiaoping
    Cohen, Joshua M.
    Campos, Verena Ramirez
    Du, Evelyn
    Silberstein, Stephen D.
    [J]. ANNALS OF NEUROLOGY, 2020, 88 : S159 - S159
12345